Health, Education & Government Life Sciences & Pharma Implantable Devices

Spine & Surgical Implants

Regulated development and commercialization journeys where clinical, quality, and market access align.

Medtronic DePuy Synthes Stryker NuVasive
Inside this journey
  1. Customer Discovery

    Align clinical objectives, scheduling constraints, stakeholder roles (surgeon, OR, VAS committee), and measurable success signals for device adoption.

    Discovery Questions

    Quick Intro: Who Are You in This Story?

    • Which role are you representing in this conversation today? Options: Spine surgeon (attending), Neurosurgeon, OR Director/Manager, Value Analysis Committee (VAC) chair, Perioperative nurse/tech, Distributor rep, Hospital procurement/supply chain, Other
    • Which facility or account are you speaking for? (hospital name / ASC / system)
    • Roughly how many spine fusion or decompression cases does this facility perform per year? Options: <50, 50–150, 151–300, 301–600, 601+
    • Which spine procedures are most critical to your team's volume and decision-making? Options: Lumbar fusion (open), Lumbar fusion (MIS), Cervical fusion, Decompression (laminectomy/discectomy), Motion preservation/arthroplasty, Other
    • When a new implant system is being evaluated here, what single outcome matters most to you? Options: Surgeon clinical outcomes, OR efficiency & operative time, Tray/instrument reliability, Cost per case, Inventory complexity, Staff ease-of-use
    • Tell us about a recent switch or trial your team ran—what went surprisingly well?

    Is the OR Quietly Resisting Change?

    • How often do instrument or implant availability issues cause delays, cancellations, or unexpected workflow changes in booked spine cases? Options: Almost every week, Monthly, A few times a year, Rarely, Never
    • Give a specific example of a day a spine case was disrupted by missing or incompatible instrumentation—what chain of events followed?
    • Who typically raises the alarm when an instrument or implant problem appears (surgeon, scrub tech, rep, scheduler, supply)? Options: Surgeon, Scrub tech/OR nurse, Distributor rep, Scheduling/central sterile, Supply chain/CS manager, Other
    • When a disruption happens, what are the most visible consequences here—patient delay, increased OR time, staff stress, billing problems, other? Options: Patient delay/cancellation, Longer operative time, Surgeon frustration, Scrub team confusion, Charge/revenue issues, Other
    • How long has your team been tolerating the frequency and impact of these disruptions? Options: Months, 1–2 years, 3–5 years, 5+ years, Not an ongoing issue

    What Happens When a Surgeon Asks for Something New?

    • When a surgeon requests a different implant or system, what single obstacle most often prevents timely adoption? Options: VAC/GPO approval, Inventory & ordering process, Lack of distributor coverage, Surgeon training concerns, Cost/contract terms, OR staff resistance
    • Walk us through the formal steps your facility takes from a surgeon request to an approved trial—where do you typically see bottlenecks?
    • Which internal stakeholders are required to sign off before a trial can proceed? Options: VAC chair, OR Director, Supply Chain/Materials, Finance/Revenue, Chief of Surgery, Infection Control, Other
    • How do you currently estimate the operational or financial risk of switching systems (e.g., canceled cases, extra OR time, inventory write-offs)? Options: Qualitative review, Historical cost analysis, Per-case cost model, We don't estimate it, Other
    • Have previous trial or onboarding plans met the surgeon’s expectations? If not, describe one unmet expectation.

    If Day One Could Be Perfect, What Would It Look Like?

    • Imagine the first proctored case went flawlessly—what three things stood out that made it feel successful?
    • Which measurable signals would you need to see during the trial to feel confident moving to full adoption? Options: Operative time within X% of baseline, No tray or implant shortages for 3 consecutive cases, Surgeon satisfaction rating, No increase in complications, OR staff comfortable with set-up, Cost per case target met
    • From your perspective, what is a realistic timeline from initial workshop to independent surgeon use? Options: <3 months, 3–6 months, 6–9 months, 9–12 months, >12 months
    • What minimum training format and rep coverage would make your team comfortable scheduling proctored cases? Options: Cadaver lab + OR simulation, Peer case observation, On-site proctor for first 3 cases, Checklist + digital resources, Hands-on in-service for OR staff
    • Describe the explicit go/no-go criteria your VAC or surgical leadership would require after initial cases?

    Who's Going to Carry the Torch—and Who Might Drop It?

    • Who is the single person here whose support is make-or-break for adoption, and what will happen if they are not on board?
    • How consistent is distributor or rep coverage across your hospital locations and satellite ASCs? Options: Consistent (same rep/team), Mostly consistent, Inconsistent by site, No formal distributor coverage, Other
    • Which responsibilities do you expect a distributor to own during a trial and after adoption? Options: Case-day instrument logistics, Proctoring support, Inventory management & reorder, Surgeon scheduling coordination, Staff training modules, Regulatory/GPO paperwork help
    • How does your OR staff prefer to receive training for a new system? Options: Hands-on in-OR training, Simulation/cadaver lab, Peer observation, Standard operating checklists, Short digital micro-learning modules
    • Do you have local surgeon champions who would actively support the change? If yes, who are they and what influence do they hold?

    Logistics That Break Trust (And How We Can Prevent It)

    • What single logistic failure in past switches damaged trust most (missing tray, wrong implant sizes, rep no-show, billing surprises)?
    • How are tray lists, sterilization turn-around, and instrument set completeness currently tracked and validated? Options: Electronic tray tracking, Paper/whiteboard lists, Central sterile logs, Distributor-managed tracking, No formal process
    • Who owns implant inventory ordering, allocation, and reconciliation across your sites? Options: Supply chain/materials, Per-site charge nurse, Distributor-managed consignment, Surgeon/privately stocked, Other
    • What contingency plans do you want in place when an instrument or implant shortage threatens a booked surgery? Options: Backup implant inventory on-site, Alternative instrument set readiness, Same-day transfer policy, Surgeon backup list, Escalation path to distributor/rep
    • How would you prefer responsibilities and day-of-case roles to be documented and shared (checklists, shared channel, EHR notes, printed run sheet)? Options: Shared messaging channel (Slack/MS Teams), Printed run sheet in chart, EHR case notes, Checklist stored in central sterile, Other

    Decisions, Timelines, and the Metrics That Matter

    • If we committed to a trial that truly minimized OR disruption, what assurances or documentation would you need before approving? Options: Written case-day responsibility matrix, Training schedule and attendees, Inventory ownership plan, Liability/insurance confirmation, Cost-neutral trial terms
    • What upcoming internal or external deadlines drive urgency for making a decision (GPO renewals, contract expirations, new surgeon start date)?
    • Which one or two KPIs will determine whether commercial leadership signs off after a trial? Options: Operative time change, Number of completed proctored cases, Tray completeness rate, Surgeon adoption rate, Per-case implant cost
    • Who is the ultimate decision-maker for proceeding from trial to full adoption, and what information do they require? Options: VAC chair, Chief of Surgery, Hospital CEO/COO, Supply chain director, Surgeon group consensus
    • What evidence from the trial (data, surgeon feedback, OR metrics) would be sufficient to close the deal for you?

    Small Commitments That Build Trust — Practical Next Steps

    • If we asked you to commit to one small, low-risk action this week to keep momentum, what would you be willing to do? Options: Schedule a 30-min planning call, Share current tray lists, Provide a date window for a cadaver lab, Identify the VAC packet owner, Nominate an OR champion
    • Which weeks or date ranges are realistic for an outcome-focused workshop or cadaver lab in the next quarter?
    • Which stakeholders must be present at the initial Solution Experience for it to be productive? Options: Lead surgeon(s), OR Director/Manager, VAC representative, Distributor rep, Central sterile lead, Finance/supply chain
    • Before that meeting, what documentation or data would you like from us to prepare (cost model, case studies, tray specs, training plan)? Options: Cost per case model, Peer case outcomes, Complete tray/instrument list, sample protocols & checklists, Training syllabus
    • Is there anything important we haven’t asked that would change how you evaluate a new spine system?
  2. Solution Experience

    Run outcome-focused workshops (cadaver lab, peer case observation, and proctored case planning) to validate workflow impact and surgeon outcomes.

    Experience Meetings

    • Pre-Workshop Alignment
    • Cadaver Lab Workshop (Hands-on Validation)
    • Peer Case Observation (Plan & On-Case Debrief)
    • Proctored Case Planning & Readiness
    • Post-Experience Validation & Go/No-Go Decision
    • Introductions & Objectives
    • Assign a single point of contact for day-of coordination for each event.
    • Recap Current State, Consequences & Goals
    • Demonstrate measurable improvement against at least one agreed KPI in the lab setting.
    • Identify and document required tray/instrument changes and procedural adjustments.
    • Obtain explicit surgeon validation that the proposed workflow addresses the stated problem.
    • Agree concrete next steps for peer observation and proctored case planning.
    • Produce a lab report with timed measurements, tray change list, and surgeon sign-offs.
    • Update tray manifests and request any missing instruments or implants from distribution.
    • Schedule peer observation dates and confirm observers and data capture templates.
    • If critical failures observed, define remediation tasks before any live case.
    • Observation Objectives & Metrics
    • Capture objective, on-case evidence showing whether lab gains translate to live OR.
    • Document operational impacts to OR staff, instrument flow, and scheduling.
    • Decide whether to proceed to proctored cases as planned or iterate on instrument/workflow changes.
    • Deliver a concise observation report including KPI comparisons, photos, and immediate surgeon feedback.
    • If gaps found, list required changes and owner assignments before proctored cases.
    • Confirm proctoring dates or additional observations based on the debrief outcome.
    • Reconfirm Future-State & Acceptance Criteria
    • Achieve a fully-signed pre-proctored-case readiness checklist with owners assigned for every risk area.
    • Confirm that all implants, trays, and rep coverage are committed to the case-day.
    • Ensure everyone understands the acceptance criteria and contingency responses.
    • Distribute the signed validation checklist and assign owners for any open items.
    • Stage implants and instrument sets at the facility and confirm inventory with central distribution.
    • Confirm travel/logistics for proctor/rep and create a day-of communication plan.
    • Publish the case-day timeline and contingency contacts to all stakeholders.
    • Synthesis of Measured Results
    • Reach a documented go/no-go decision based on objective evidence and surgeon readiness.
    • Create a prioritized corrective action list with owners and deadlines for any remaining gaps.
    • Establish the trial start date and first validation checkpoint if approved.
    • Prepare and distribute the post-experience report summarizing metrics, decisions, and assigned actions.
    • If 'go', schedule first proctored case(s) and publish the deployment timeline and owners.
    • If 'iterate', define required follow-up (additional lab, instrument mods, training) and timelines.
    • Set the date for the first post-deployment validation checkpoint and invite stakeholders.
    • Produce a single-sentence current-state statement that all stakeholders accept.
    • Agree on quantified consequences that create urgency to change.
    • Define the operational future-state and 3–5 KPIs to validate it.
    • Confirm calendar dates, participants, and pre-work assignments for the cadaver lab and peer observation.
    • Distribute pre-work template and collect OR case lists, imaging, and existing tray lists.
    • Reserve cadaver lab facility and confirm required implants/instruments on the lab manifest.
    • Confirm proctor and peer surgeon availability and tentative observation dates.
    • Select Peer Case(s) & Logistics
    • Re-evaluate Consequence Positioning
    • Technique & Workflow Demonstration
    • Final Case Selection & Schedule
    • One-Sentence Current State
    • Surgeon & OR Team Readiness Assessment
    • Surgeon Hands-on Stations
    • Tray, Implant & Inventory Checklist
    • Explicit Consequences
    • Data Capture Protocol
    • Rep & Distributor Coverage Plan
    • Pre-op Planning Review
    • Define Future-State Outcomes
    • Objective Measurements & Time Trials
    • Operational Readiness Review
    • Instrument Tray & Workflow Validation
    • Close Gaps & Assign Corrective Actions
    • Success Signals & KPIs
    • Case Workflow Run-through & Contingency Plans
  3. Solution Scope

    Define implant and instrument configurations, distributor OR coverage, trial case plan, inventory responsibilities, training modules, and acceptance criteria.

    Scope Configuration

    • Deliver complete implant case kits
    • Supply sterile instrument trays
    • Provide intraoperative technical rep support
    • Provide proctored initial surgical cases
    • Run cadaver surgical workshops
    • Deploy navigation-compatible instrument sets
    • Supply minimally invasive access kits
    • Deliver expandable interbody cage systems
    • Perform instrument reprocessing and restock
    • Consign implant inventory to hospital
    • Transfer instrument trays between facilities
    • Provide on-site OR staff instrument orientation
    • Supply emergency backup implant sets
    • Install patient-specific surgical guides

    Scope Questions

    Deliver complete implant case kits

    • Do you require single-case, pre-packaged complete kits or modular pick-lists assembled per case? Options: Single-case complete kits, Modular pick-lists, Both, Not sure
    • What is your expected average number of cases per month that will use these kits? Options: 1-5, 6-20, 21-50, 50+, Specify
    • Which specific implant types, levels, or sizes must be guaranteed in each kit (e.g., pedicle screw diameters, cage footprints)?
    • Do you require vendor labeling that matches hospital charge / procedure codes or OR-specific labeling? Options: Standard vendor labels, Hospital-specific labels, Both, Other
    • Who will be responsible for kit inventory tracking and restocking between cases? Options: Distributor/vendor, Hospital supply chain, Consignment with vendor reconciliation, Shared responsibility
    • What acceptance criteria must be met at time-zero (before skin incision) for a kit to be considered complete? Options: All implants & instruments present, Critical items present; non-critical can be substituted, Surgeon sign-off required, Other

    Supply sterile instrument trays

    • Do you require vendor-supplied sterile trays (single-use or sterilized by vendor) or hospital-sterilized trays? Options: Vendor-supplied sterile trays, Hospital-sterilized reusable trays, Mixed approach
    • How many instrument sets should be available per OR per scheduled block (including backups)? Options: 1 set, 2 sets, 3+ sets, Varies by case
    • Do you have tray set lists or do you need the vendor/distributor to propose tray contents? Options: Hospital will provide set lists, Vendor to propose and iterate, Shared review
    • What is your required turnaround time for reprocessing and returning a tray to sterile stock? Options: Same-day turnaround, 24 hours, 48 hours, Other
    • Who is responsible for instrument repair and replacement when damage is identified? Options: Vendor/distributor, Hospital biomed/sterile processing, Third-party repair, Shared
    • Are there specific sterilization constraints (low-temp sterilization for trackers, peel-packs, validated cycles) the vendor must meet? Options: Standard steam acceptable, Low-temp or special cycles required, We will confirm per instrument, Other

    Provide intraoperative technical rep support

    • Should a technical representative be present for all trial and proctored cases or only for a subset? Options: Present for all trial/proctored cases, Only initial cases, On-call/remote support, As scheduled
    • What portion of the case must the rep attend (setup only, critical steps, entire case)? Options: Setup & implant insertion, Critical procedural steps only, Entire operative case, Surgeon discretion
    • Are there hospital credentialing, badge, or vaccination requirements that the rep must satisfy before OR access? Options: Yes - list will be provided, No, Pending hospital approval
    • What clinical background or competency level do you require for the rep (RN, CST, clinical specialist)? Options: RN/clinical specialist, Experienced surgical tech/CST, Basic product training acceptable, Surgeon preference
    • Who is the escalation contact and expected response time for intraoperative device or instrument issues?
    • What acceptance metrics will determine satisfactory rep support (surgeon satisfaction, zero instrument-related delays, on-time case completion)? Options: Surgeon satisfaction, No instrument-related delays, Case meets scheduled OR time targets, Other

    Provide proctored initial surgical cases

    • How many proctored cases does the surgeon request before independent use is authorized? Options: 1-2, 3-5, 6-10, 10+, Specify
    • What type of proctor is required (peer surgeon proctor, company clinical specialist, or hybrid)? Options: Peer surgeon proctor, Company clinical specialist, Both, Other
    • What scheduling windows, blackout dates, or OR block constraints must we accommodate for proctored cases?
    • Who will handle proctor travel, credentialing, and hospital privileges if an external surgeon proctor is used? Options: Vendor covers travel & credentialing, Hospital handles credentialing, Costs split, Other
    • What documentation or sign-off is required after each proctored case (proctor report, surgeon attestation, operative note addendum)? Options: Proctor report, Surgeon sign-off, Both, No additional documentation
    • What are the success criteria for concluding the proctoring phase (surgeon independence, operative time target, complication threshold)? Options: Surgeon independent on subsequent case, Operative time within agreed target, Surgeon satisfaction survey, Other

    Run cadaver surgical workshops

    • How many workshop seats or surgeon attendees should be planned for each session? Options: 4-8 seats, 9-16 seats, 16+ seats, Specify
    • Which procedures and techniques should be included (e.g., TLIF, ALIF, PLIF, cervical approaches)? Options: TLIF, ALIF, PLIF, Cervical, Other
    • Do you require CME accreditation and formal certificates for attendees? Options: Yes, No
    • Do you prefer vendor-hosted off-site labs, on-site hospital labs, or hybrid formats? Options: Off-site cadaver lab, On-site hospital lab, Hybrid
    • What equipment and instrument sets must the vendor supply for the workshop versus what the hospital will provide? Options: Vendor supplies all instruments, Hospital supplies OR equipment, Shared responsibility
    • Which measurable outcomes from the workshop are important (surgeon confidence, procedural competency, decision-making for implants)? Options: Surgeon confidence, Technical competency, Willingness to trial cases, Other

    Deploy navigation-compatible instrument sets

    • Does the site currently have navigation hardware/software, or will it be procured concurrently? Options: Existing navigation system, No navigation yet, Planned installation
    • Which navigation platforms must our instruments be compatible with? Options: Brainlab, Medtronic Stealth, Stryker NAV3, Other (specify)
    • Are instrument adapters, trackers, or sterile drape interfaces required for compatibility? Options: Yes - adapters/trackers required, No - native compatibility, Depends on platform
    • Who will perform integration testing and clinical validation of navigation workflows (vendor, hospital IT/biomed, distributor)? Options: Vendor, Hospital IT/Biomed, Distributor, Shared
    • What acceptance criteria define acceptable navigation performance (target accuracy, registration time, OR workflow fit)?
    • Are there sterilization or tracker handling constraints (low-temp sterilization, single-use trackers)? Options: Standard sterilization, Low-temp required, Single-use trackers, Other

    Supply minimally invasive access kits

    • Which MIS approaches should the kits support (tubular retractors, percutaneous screws, endoscopic, lateral approaches)? Options: Tubular retractors, Percutaneous screw kits, Endoscopic, Lateral/XLIF, Other
    • How many MIS kits should be staged per room or per block? Options: 1 per room, 2 per room, Depends on schedule
    • Do you prefer single-use disposable consumables or reusable MIS instruments? Options: Single-use consumables, Reusable instruments, Mixed approach
    • Are there imaging system compatibility constraints (fluoroscopy-only, O-arm, navigation) that affect kit contents? Options: Fluoroscopy, O-arm, Navigation, Other
    • Will additional MIS-specific proctoring or staff training be required before independent use? Options: Yes - proctoring required, No, As-needed
    • What acceptance criteria determine MIS kit readiness on case day (complete instruments, backup kits, surgeon sign-off)? Options: Complete instruments present, Backup kit available, Surgeon sign-off, Other

    Deliver expandable interbody cage systems

    • Which cage footprints, heights, lordosis angles, and expansion ranges must be stocked?
    • Do you require trial/demo implants and sizing trials for surgeon evaluation prior to using implants in patients? Options: Yes - trial implants needed, No - proceed with implants, Partial/demo inventory
    • What inventory model do you prefer for cages: consignment, hospital purchase, vendor-stocked with case billing? Options: Consignment, Hospital purchase, Vendor-stocked billing by use, Custom
    • Are the expandable cages required to be compatible with MIS insertion instruments or specific MIS workflows? Options: Yes - MIS-compatible, No - open approach only, Both
    • Are there sterilization or single-use instrument constraints associated with cage deployment instruments? Options: Single-use implant, reusable instruments, Single-use instruments, Reusable instruments
    • What clinical or radiographic acceptance criteria will you use to evaluate cage performance post-implantation? Options: Surgeon satisfaction, Radiographic placement criteria, Fusion progress metrics, Other

    Perform instrument reprocessing and restock

    • Who will be responsible for reprocessing instrument trays between cases? Options: Vendor/distributor reprocessing, Hospital SPD, Third-party reprocessor, Shared
    • What is the required SLA for tray turnaround and restock to support scheduled cases? Options: Same day, 24 hours, 48 hours, Custom agreement
    • Do you require electronic inventory tracking (barcode/RFID) and automated restock notifications? Options: Yes - barcode/RFID, No, Planned implementation
    • Who bears cost for lost, damaged, or non-repairable instruments identified during reprocessing? Options: Vendor, Hospital, Consignment terms apply, Shared
    • Do you require sterilization cycle documentation and tray count logs be provided after each reprocessing cycle? Options: Yes, No
    • How often should preventive maintenance and calibration of reusable instruments be scheduled and documented? Options: Monthly, Quarterly, Annually, Per vendor recommendation

    Consign implant inventory to hospital

    • Which hospital locations or ORs should hold consigned stock and what is the maximum consignment value per location?
    • What billing trigger should be used for consignment (case use, monthly inventory reconciliation, periodic consumption report)? Options: Billed on case use, Monthly inventory invoice, Periodic reconciliation, Other
    • Who will perform inventory audits and at what frequency (weekly, monthly, quarterly)? Options: Vendor weekly, Hospital monthly, Third-party audits, Custom schedule
    • What insurance, liability, and indemnification terms does the hospital require for consigned stock? Options: Vendor carries insurance, Hospital carries insurance, Shared liability
    • What is the policy for returning expired, unused, or near-expiry implants from consignment? Options: Returnable, Non-returnable, Credit on rotation, Other
    • Do you require EMR/ERP integration (material management) for real-time consignment tracking and charging? Options: Yes, No
  4. Mutual Commit

    Finalize commercial and trial terms, GPO/compliance items, distributor obligations, surgeon proctoring commitments, and go/no-go criteria.

    Agreement Modules

    • Statement of Work (SOW)
    • Commercial Terms & Purchase Order
    • Trial / Evaluation Agreement
    • GPO / Contract Addendum
    • Distributor Service & OR Coverage Agreement
    • Surgeon Proctoring & Training Commitment
    • Inventory Allocation & Consignment Agreement
    • Acceptance Criteria & Go/No-Go Checklist
    • Compliance, Credentialing & Regulatory Exhibit
    • Instrumentation Delivery & Validation Schedule
    • Insurance, Indemnification & Liability Terms
    • Data & Outcomes Sharing Agreement
    • Implementation Project Plan & Owners
    • Change Order & Amendment Process
  5. Deployment

    Operationalize rollout with readiness checks, enablement, and outcome validation.

    1. Pre-Deployment Readiness

      Confirm tray lists, stock allocations, rep coverage schedule, OR staffing readiness, and contingency plans for booked surgeries.

      Readiness Questions

      Starting with a Bit About You (quick warm-up)

      • Which best describes your primary role today? Options: Spine surgeon (Orthopedic), Spine surgeon (Neurosurgery), OR Director/Manager, Value Analysis Committee Chair, Supply Chain Manager, Distributor/Rep, Other
      • Where do you practice most of your spinal cases? Options: Academic medical center, Community hospital, Ambulatory surgery center (ASC), Hybrid hospital/ASC system, Private practice with hospital privileges, Other
      • Roughly how many spine fusion or decompression cases does your site schedule per month? Options: 0–5, 6–15, 16–30, 31–50, 51+
      • What usually prompts you or your hospital to consider a new implant system? (Select all that apply) Options: New surgeon onboarding, GPO contract change, Clinical evidence / new technology, Cost savings opportunity, Surgeon preference shift, Supply reliability issues, Other
      • Briefly, what's one strong feeling you have about past product switches that you’d want us to know?

      What’s Secretly Costing Your Team in the OR?

      • If you had to name the single hidden cost our current implant or instrument process creates for your team, what would it be?
      • How often do issues with instruments, trays, or rep coverage cause a meaningful disruption (delay or cancellation) to scheduled spine cases? Options: Weekly or more, Monthly, Quarterly, Rarely/never
      • When a disruption happens, what does it typically look and feel like for the surgeon, the nursing team, and the patient?
      • Which of these tends to be the root cause when things go wrong? Options: Missing instruments on tray, Incorrect implant inventory, Distributor/rep not present, OR staff unfamiliarity, Late delivery from central sterile, Documentation/labeling errors, Other
      • Tell us about a recent case where the process broke—what happened, how long was it, and what did you wish had been different?

      Who Really Decides — and Who’s Quietly Holding a Veto?

      • Who at your institution would surprise us by having the most influence over implant selection? Options: Chief of Surgery, OR Director, Vascular/Anaesthesia influences, Value Analysis Committee Chair, Finance/Materials Management, Lead Surgeon(s), GPO/Contracting rep, Other
      • List the stakeholders who must sign off before a new spine system is approved and indicate how they typically weigh clinical vs. economic factors.
      • Which factors carry the most weight for decision-makers here? (pick up to 4) Options: Clinical outcomes/evidence, Surgeon preference/familiarity, Cost per case, Rep/Distributor availability in OR, Tray/inventory reliability, Training requirements, GPO/compliance alignment
      • How long does your approval process typically take from clinical interest to signed trial or contract? Options: <1 month, 1–3 months, 3–6 months, 6–12 months, 12+ months
      • Has a previous approval stalled unexpectedly? If yes, what stopped it and who ultimately pushed it forward?

      When the Schedule Goes Off the Rails

      • How many booked spine cases in the last 12 months were delayed or canceled due to implant/instrument/rep issues? Options: 0, 1–2, 3–5, 6–10, 10+
      • What is an acceptable threshold for day-of cancellations related to product/logistics before leadership considers it a critical problem? Options: 0% (intolerable), <1%, 1–3%, 3–5%, >5%
      • What contingencies do you currently use when a tray or implant is missing—temporary implants, alternate vendor, reschedule, other? Options: Switch to back-up vendor implants, Use existing stock from another OR, Reschedule patient, On-call rep/loaner instruments, Convert to a simpler procedure, Other
      • How far in advance do cases need full tray and implant confirmation for your team to feel comfortable (hours/days)? Options: Same day morning, 24 hours, 48–72 hours, One week, Other
      • Describe an ideal day-of flow when everything goes smoothly—who shows up, when, and what checks happen before incision?

      What Would Make You Call Adoption a Clear Win?

      • If you could pick one measurable outcome that proves adoption succeeded, what would it be? Options: Reduced operative time, Lower complication/revision rate, Improved patient-reported outcomes, Reduction in instrument-related delays, Surgeon confidence to operate independently, Cost per case reduction
      • What specific numeric targets would feel compelling for that outcome (e.g., minutes saved, % fewer cancellations, LOS reduction)?
      • Beyond numbers, what emotional or cultural signs would tell you the team has truly adopted the system? Options: Nurses request the system, Surgeons recommend it to peers, OR staff set up trays without guidance, Fewer last-minute phone calls, Positive patient feedback
      • Which timeframe feels realistic to reach those targets after starting proctored cases? Options: 1–3 months, 3–6 months, 6–12 months, 12+ months
      • Are there any payer, regulatory, or GPO metrics we should include in the success definition?

      Training, Proctoring and the Learning Curve — What Would Cure the Squeeze?

      • What single change to training would reduce the surgeon learning curve the most?
      • Which training formats have produced the best adoption for your team in the past? (select up to 3) Options: Cadaver lab/workshop, Proctored live cases, Peer-to-peer observation, Simulation/VR practice, Concise step-by-step videos, In-OR scrub tech training sessions
      • How many proctored cases does a typical surgeon on your team require before they’re comfortable operating alone with a new system? Options: 1–2, 3–5, 6–10, 10+, Depends on case complexity
      • What scheduling constraints usually limit when we can run labs or proctored cases (staff availability, OR time, patient selection, other)? Options: Surgeon clinic schedule, OR block time, Patient availability, Nursing/staff coverage, Proctor travel constraints, Other
      • Describe a past training rollout that worked well—what logistics or behaviors made it stick?

      Tray Reality Check — Where Does Supply Chain Meet the Sterile Field?

      • If you had to predict, which link in the tray/inventory chain is most likely to cause day-of problems? Options: Central sterile processing errors, Distributor packing errors, Transport/logistics delays, OR set-up mistakes, Stock counting inaccuracies, Instrument maintenance issues
      • How are tray completeness and instrument checks currently documented before a spine case? Options: Paper checklist, Electronic checklist in EMR, Sterile processing log, Distributor confirmation email/portal, Ad-hoc verbal confirmation, Other
      • Who is accountable at your site for ensuring implant inventory levels across accounts—materials management, lead surgeon, distributor, or someone else? Options: Materials Management/Supply Chain, Lead Surgeon / Surgeon team, OR Manager/Director, Distributor rep, Value Analysis Committee, Other
      • What minimum days-on-hand of critical implants and instrument trays do you want available at each site? Options: Same day (0–1 day), 2–3 days, 4–7 days, 7+ days, We rely on just-in-time delivery
      • What tracking or barcode systems do you use today for implants/instruments, if any? Options: None, Hospital inventory software, Vendor portal, RFID/barcode systems, Manual logs, Other
      • Share a small pain-point: one instrument or kit that repeatedly causes friction and why.

      Risk, Escalation, and Day-Of Ownership — Who Fixes It Fast?

      • When something goes wrong on the day of surgery, who do you expect to resolve it immediately? Options: On-site distributor rep, Company clinical specialist, OR director/manager, Surgeon’s personal rep/assistant, Supply chain manager, Other
      • What is your desired rep coverage model for proctored and early-adoption cases? (pick up to 2) Options: Dedicated rep on-site for every case, Regional on-call rep, Clinical specialist + rep combo, Remote support with on-site scrub tech, Distributor rotational coverage
      • What is an acceptable response time from a rep or company clinical specialist for urgent day-of issues? Options: <15 minutes, 15–30 minutes, 30–60 minutes, >60 minutes, No expectation / variable
      • If we built formal contingency plans, which of these would you want included? Options: Loaner instrument sets, Back-up implant inventory, Alternate qualified rep list, Emergency protocol checklist, Pre-identified conversion strategies, Other
      • Who should be the single escalation contact at our company and at your site for day-of problems?

      Scheduling the First Cases — If There Were No Fears, What Would You Do?

      • If you could book proctored cases without worrying about logistics, how many would you schedule in the first 30 days? Options: 1–2, 3–5, 6–10, 10+, Depends on surgeon availability
      • Which case types do you prefer for initial proctoring (select all that apply)? Options: Single-level lumbar fusion, Multi-level fusion, Cervical fusion, MIS TLIF/PLIF, Decompression only cases, Other
      • What patient selection criteria should we use to minimize risk during early cases?
      • What OR block times or surgeon schedules create the best window for proctored cases here? Options: First case of the day, Second/third case, Dedicated training block, Weekend/extended day, Flexible based on patient
      • What acceptance criteria should trigger moving a surgeon from proctored to independent cases? Options: Number of proctored cases, Surgeon confidence/self-assessment, OR staff checklist completion, Operative time within target, Clinical outcomes at X weeks, Combination of above

      Final Thoughts — What Would Make You Confident to Move Forward?

      • What's the single biggest barrier left that would prevent you from trying a structured trial of our system?
      • How would you prefer we keep communication during the trial—email updates, shared dashboard, weekly calls, or in-person check-ins? Options: Email updates, Shared online dashboard, Weekly video call, On-site visits, Ad-hoc as issues arise
      • Who should be included on all trial communications from your side (name and role)?
      • Realistically, when would you be ready to start a discovery-to-proctor timeline if the above concerns were addressed? Options: Immediately, Within 1 month, 1–3 months, 3–6 months, Unsure
      • Anything else we haven’t asked that would help us design a deployment plan that feels safe, fast, and surgeon-friendly?
    2. Deployment Enablement

      Schedule proctored cases, deliver and validate instrument sets, execute OR staff training, and assign owners for case-day coverage.

    3. Validation Checklist

      Verify tray completeness, inventory levels, rep presence, operative time targets, and surgeon acceptance after initial cases.

      Validation Questions

      Tell Us About Your Spine Practice Today

      • How many instrumented spine cases do you perform at this facility per month? Options: 0-5, 6-15, 16-30, 31-60, 60+
      • Which procedures represent the majority of your case mix at this site (select all that apply)? Options: Posterior lumbar fusion (open), Posterior lumbar fusion (MIS), Interbody fusion (PLIF/TLIF/ALIF), Cervical fusion, Decompression only (laminectomy/discectomy), Motion-preservation procedures
      • How is this OR account structured? Options: Hospital-employed surgeons, Private practice surgeons, ASC with multiple independent surgeons, Mixed/Other
      • Who typically makes the final decision about implant/system selection here? Options: Lead spine surgeon, Group of surgeons, OR director, Value Analysis Committee (VAC) / VAS chair, Procurement/GPO
      • When a new spine surgeon joins or a contract rolls over, how do you usually evaluate new implant systems? Options: Cadaver lab + proctored cases, Peer observation + limited trial cases, Vendor demos + clinical data review, GPO-led competitive bid process
      • What matters most to you when choosing a new spinal implant system? Options: Clinical outcomes and evidence, Instrument ergonomics and workflow, Distributor rep presence in OR, Inventory reliability, Total cost of ownership

      Is Staying With the Old System Actually Costing You?

      • How often do instrument or tray issues cause a delay or cancellation of a scheduled spine case here? Options: Never, Rarely (a few times/year), Occasionally (monthly), Often (weekly), Regularly (multiple times/week)
      • Tell us about the most recent case that was impacted by implant or instrument problems—what happened and what was the downstream effect?
      • How long have you been tolerating those kinds of disruptions? Options: Less than 6 months, 6–12 months, 1–2 years, Over 2 years
      • Beyond time and cost, how do these disruptions affect surgeon confidence, team morale, or patient relationships here?
      • What interim workarounds do you and your team use when a tray or implant is missing (select all that apply)? Options: Use backup vendor instruments, Delay case start, Borrow from another hospital account, Modify surgical plan intra-op, Cancel patient

      Who Really Holds the Keys to Adoption?

      • If adopting a new system is harder than expected, who would raise the first alarm inside your organization? Options: Lead surgeon, OR director/manager, VAC/VAS chair, Procurement/GPO rep, Anesthesiology or nursing leadership
      • Which stakeholders must be convinced before a trial moves from proctoring to routine use? (select all that apply) Options: Individual surgeons, Surgical partners/group practice, OR nursing staff, VAC/VAS committee, Supply chain/procurement, Distributors/rep leadership
      • Describe a past adoption where one stakeholder blocked progress—what was their concern and how was it (or wasn’t it) resolved?
      • Are there external contract constraints (GPO, regional agreements) that will limit options for suppliers or trial duration here? Options: Yes—GPO restrictions, Yes—existing supplier contracts, No significant constraints, Unsure / need to check
      • When you think about engaging suppliers, how do you prefer we coordinate with stakeholders (select top 2)? Options: Direct surgeon-to-vendor meetings, VAC-directed evaluation, Distributor-led logistics + rep support, Joint clinical committee meetings, On-site hands-on workshops
      • When a new surgeon requires a different system, what is your typical onboarding timeline and what are the usual bottlenecks?

      What’s Getting in the Way of Reliable Cases?

      • How often do you experience implant stockouts at the moment of case preparation? Options: Never, Rarely, Occasionally, Monthly, Weekly
      • How frequently do instrument trays arrive incomplete or require re-sterilization prior to cases? Options: Never, Rarely, Occasionally, Often, Very often
      • Who currently owns inventory accuracy and restocking across your hospital accounts? Options: Hospital supply chain team, Local distributor, Centralized vendor logistics, Surgeon/team manages manually
      • Which combination of responsibilities would you find most acceptable for trials (select all that apply)? Options: Vendor ships and maintains stock, Distributor manages daily OR coverage and trays, Hospital provides base inventory, vendor supplements, Hybrid: shared responsibilities by procedure
      • Describe a time an inventory or tray issue changed the surgical plan—what were the clinical or operational consequences?
      • What visibility or reporting on inventory would reduce your stress about scheduled cases? Options: Real-time stock portal, Automated restock alerts, Pre-op tray check checklist, Weekly inventory reconciliation

      What Would a Successful Early Trial Actually Show?

      • What is the one clinical or operational metric that would make you say a new system is worth adopting? Options: Reduced operative time, Lower complication/readmission rate, Improved instrument ergonomics, Fewer tray/inventory issues, Surgeon satisfaction
      • How much variation in operative time (minutes or percent) is acceptable while surgeons are learning a new system? Options: No tolerance, Up to 10% increase, 10–20% increase, 20–30% increase, More than 30%
      • Which measurable 'success signals' do you want tracked during the trial period (select all that apply)? Options: Operative time, Estimated blood loss, Industry-standard clinical outcomes (fusion rates), Tray completeness rate, Number of instrument-related delays, Surgeon comfort/acceptance
      • What would surgeon acceptance look like to you after the first 3–5 proctored cases? Options: Comfort to proceed independently, Preference for continued proctoring, Partial adoption for select procedures, Not interested in adoption
      • How soon after the initial proctored cases do you expect objective outcome data (and what type) to inform a decision? Options: 30 days—operative metrics only, 90 days—early clinical outcomes, 6 months—functional outcomes, 12 months—fusion and long-term metrics
      • What would be a deal-breaker result from the early cases?

      Where Could a Distributor or Rep Actually Win Your Trust?

      • If a rep or distributor failed to show for an index case, what would that signal to you about the vendor? Options: Unreliable partner, Logistical problem we can tolerate once, Trainable issue with patchable gaps, Deal-breaker
      • Which rep behaviors matter most in the OR for you and your team (select up to 3)? Options: Proactive tray checks pre-case, Hands-on instrument handling, Clear speaking and OR etiquette, Clinical knowledge to advise the surgeon, Troubleshooting under pressure
      • How do you prefer distributor coverage to be scheduled for a trial (select one)? Options: Dedicated rep for every case, Regional coverage rotated week-to-week, On-call rep with guaranteed arrival time, Hybrid with remote backup support
      • What training formats help OR staff become comfortable fastest (select all that apply)? Options: In-service on site, Hands-on cadaver lab, Short instructional videos, Checklist and quick-reference cards, Proctored on-the-job training
      • Share an example of a rep who positively impacted case flow—what did they do differently?
      • What communication cadence from the rep/vendor would make you feel supported during a trial? Options: Daily pre-op check-in, Weekly summary, As-needed alerts, Monthly review meeting

      What Are You Willing to Commit to — and What Can’t Move?

      • Which trial commitments are realistic for your team right now (select all that apply)? Options: 3 proctored cases, 5–10 proctored cases, Cadaver lab participation, Peer observation day, Short-term exclusive use for select cases
      • Are there commercial or compliance constraints that would block a short trial here (e.g., GPO exclusivity, procurement rules)? Options: Yes—GPO exclusivity, Yes—hospital procurement rules, No known constraints, Unsure, need to check
      • What explicit go/no-go criteria should we agree on before starting a trial (clinical, logistical, or contractual)?
      • If an early proctored case fails to meet expectations, what contingency steps would you want predefined? Options: Immediate case review and corrective action, Pause further proctoring until fixes, Return to legacy system for scheduling, Escalate to vendor leadership
      • Who has signing authority to accept a system into routine use at this site? Options: Lead surgeon(s), VAC/VAS chair, Hospital procurement, Committee approval required
      • What timeline would be acceptable to reach a mutual decision after the last proctored case? Options: Within 1 week, Within 1 month, 1–3 months, Longer than 3 months

      Let’s Map the Next Steps — What Would Make This Easy?

      • How open are you to participating in a cadaver lab or peer observation as the next step? Options: Very open—schedule it soon, Interested but timing matters, Maybe—need more info, Not interested
      • What pilot timeline would be realistic for you to start proctored cases? Options: Within 2 weeks, 1 month, 2–3 months, 3–6 months
      • What specific support or guarantees would reduce the perceived risk enough for you to greenlight a short trial?
      • Which 30/90/180-day metrics would you like included in a shared dashboard to judge success (select all that apply)? Options: Operative time trends, Tray completeness rate, Number of instrument-related delays, Surgeon satisfaction scores, Clinical complication/readmission rates
      • Who else should we bring into the conversation to accelerate alignment (name roles or specific people)?
      • Are there any remaining concerns that, if addressed, would make you confident to move forward?
  6. Success

    Review clinical and operational outcomes against success signals, capture lessons learned, and maintain a shared channel for issues and enhancements.

    Success Reviews

    • Final Outcomes Review — Clinical & Operational
    • Lessons Learned & Continuous Improvement Workshop
    • Operational Readiness Handover — OR, Supply Chain & Distributor
    • Surgeon & OR Staff Feedback Session
    • Shared Issues & Enhancements Channel Setup + Governance

    Issues & Enhancements

    • Agree on additional training, reference materials, or proctoring if required.
    • One‑sentence Future State
    • Establish single owners for inventory, rep coverage, and OR training for steady‑state operations.
    • Agree on concrete inventory and tray standards that will prevent case delays.
    • Set monitoring cadence and SLAs to sustain adoption and quickly resolve issues.
    • Publish definitive tray lists and inventory thresholds to supply chain and distribution partners.
    • Formalize rep coverage schedule and backup roster with distributor signatures.
    • Create an operational runbook (day‑of checklist, escalation path) and distribute to OR managers.
    • Validated Current State from Users
    • Obtain explicit surgeon confirmation on acceptance criteria or documented objections.
    • Capture frontline OR staff issues that could cause future case delays and identify quick mitigations.
    • One‑sentence Current State
    • Compile a surgeon acceptance log with signed confirmations or documented objections.
    • Prepare quick reference guides and schedule targeted OR staff refreshers based on requests.
    • If objections remain, schedule targeted proctored cases or peer observations to close gaps.
    • Purpose & Channel Choice
    • Create a single source of truth for issues and enhancement requests with clear triage rules.
    • Define owners, SLAs, and escalation paths so issues are resolved predictably.
    • Establish a governance cadence to review trends and prioritize systemic fixes.
    • Create the shared channel and onboard all stakeholders with credentials and guidelines.
    • Publish triage matrix and SLA document to the channel and operational teams.
    • Schedule recurring governance meetings (monthly) and a rolling review of the enhancement backlog.
    • Confirm alignment on whether the trial met the predefined clinical and operational success signals.
    • Quantify the operational and financial consequences of the results.
    • Assign owners and timelines for either formal adoption or targeted remediation.
    • Produce and distribute a formal outcomes report mapping each success signal to measured data and decision recommendation.
    • Assign remediation owners and create a 30/60/90 day plan for any unmet signals.
    • Schedule governance cadence for monitoring agreed KPIs if moving to adoption.
    • Brief Recap of Outcomes
    • Document concrete lessons learned and root causes for top operational and clinical variances.
    • Agree on a prioritized list of improvements with owners and pilot plans.
    • Define measurable success criteria for each pilot change to validate impact.
    • Create a prioritized improvement backlog with owners, estimated effort, and target metrics.
    • Initiate pilots for top 1–3 improvements and schedule checkpoints.
    • Update training materials or SOPs based on agreed changes and distribute to OR staff and reps.
    • Issue Triage & SLAs
    • Surgeon Satisfaction & Case Review
    • Clinical Outcomes Summary
    • Incident & Near‑miss Review
    • Tray & Inventory Standards
    • Operational Metrics Summary
    • Enhancement Backlog Process
    • Rep & Distributor Coverage Plan
    • OR Staff Workflow & Setup Feedback
    • Root Cause Analysis (Fishbone/5 Whys)
    • Consequence & Financial Impact
    • Improvement Brainstorm & Prioritization
    • Roles, Escalation & Governance Cadence
    • Force Validation of Acceptance Criteria
    • OR Staffing & Training Handover
    • Onboarding & Channel Norms
    • Validation & Decision
    • Monitoring, Reporting & SLAs
    • Pilot Selection & Success Definition
    • Quick Wins & Training Requests
    • Next Steps & Owner Assignments
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.